InvestorsHub Logo

Lishur

10/26/23 9:13 PM

#4890 RE: soma2022 #4887

Market is brutal, short term. All the best.

Emannow

10/26/23 9:50 PM

#4891 RE: soma2022 #4887

Spoke to an injector earlier this week who was a big Botox user. She has now injected over 500 patients with Daxi and her patients are charged the same price for Botox or Daxi. Same price to the patient for 40 units of Botox/80 units of Daxi or 50 units of Botox /100 units of Daxi, etc….same price for both.

It took this very experienced injector 4 months to perfect her Daxi injections. The frontalis now gets a 2cc Daxi dilution ( to create more spread) and the galbellar and crows feet get a 1 cc Daxi dilution. She has both dilutions pre-drawn in B&D syringes in separate trays to create more efficiency in the patient room.

Her words, “Every patient now chooses Daxi over Botox due to the 24 hrs onset, longer duration of action and the peptide is icing on the cake creating the beautiful skin tone.”

She believes the majority of injectors in the USA are still working through this learning curve and once a patient is injected with Daxi, the patient will never return to Botox.

According to other conversations, Q4 Daxi and RHA sales are both selling very well.